15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Celularity Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $6.00 to $6.00, so the covering firms are broadly aligned. The average target of $6.00 sits 649% above the current $0.80. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.00 next quarter toward $0.00 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Celularity Inc.
As of Aug, 1 of 1 firms rate CELU a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CELU EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 0 analysts
Next period, 0 analysts expect Celularity Inc to earn $0.00 a share (range $0.00 – $0.00), versus — a year earlier. , growing to $0.00 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 0 analysts
Revenue is expected to reach — (range — – —).
Top analysts covering Celularity Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CELU.
#1
SB
Steve Brozak
WBB Securities
Buy
$6.00+649.3% to target
Coverage
—
+ Follow
#2
SB
Stephen Brozak
WBB Securities
Buy
$6.00+649.3% to target
Coverage
—
+ Follow
CELU stock forecast FAQ
What is CELU's average 12-month price target?+
The 1 analysts with a live target average $6.00 for Celularity Inc over the next 12 months, ranging from a $6.00 high to a $6.00 low.
Is CELU stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover CELU?+
1 analysts have an active rating on Celularity Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering CELU?+
Among analysts who currently cover CELU, Steve Brozak of WBB Securities has the strongest overall Quantellect track record. Their current call is Buy with a $6.00 target.
What is Celularity Inc's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 0 analysts, rising to $0.00 the following year.
How much revenue is Celularity Inc expected to report next quarter?+
Consensus revenue is — (range — – —), growing to — next year.
Have analysts been upgrading or downgrading CELU lately?+
As of Aug, 1 of 1 firms rate CELU a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CELU calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
